Basis: Latest reported fiscal quarter. Source: stored company filings and market data; unavailable inputs remain N/A.
Is the net profit margin high or low?
The net profit margin of 5.17% is 66% below its 5-year average of 15.39%, near the low end of its 5-year range (-0.72%–138.22%).
As of the fiscal period ended Tuesday, June 30, 2026. 66.38% below its 12-month average of 15.39%.
Reported quarterly profit margin; no daily interpolation.
NET PROFIT MARGIN
5.17%
NET PROFIT MARGIN AVG TTM
15.39%
NET PROFIT MARGIN AVG 3Y
13.61%
NET PROFIT MARGIN AVG 5Y
15.39%
NET PROFIT MARGIN AVG 10Y
12.97%
NET PROFIT MARGIN AVG 15Y
13.22%
NET PROFIT MARGIN AVG 20Y
15.59%
CURRENT VS TTM AVG
-66.38%
CURRENT VS 3Y AVG
-62.00%
CURRENT VS 5Y AVG
-66.38%
CURRENT VS 10Y AVG
-60.13%
CURRENT VS 15Y AVG
-60.88%
CURRENT VS 20Y AVG
-66.83%
SECTOR MEDIAN · HEALTHCARE
8.91%
median of 76 covered companies
CURRENT VS SECTOR MEDIAN
-41.94%
vs the sector median at left
Market Cap
$105.58B
Net Profit Margin
1.12%
TTM Avg
1.05%
3Y Avg
1.09%
5Y Avg
0.48%
Market Cap
$89.08B
Net Profit Margin
8.77%
TTM Avg
8.57%
3Y Avg
8.64%
5Y Avg
8.95%
Market Cap
$116.07B
Net Profit Margin
13.20%
TTM Avg
13.55%
3Y Avg
12.62%
5Y Avg
13.06%
Market Cap
$84.66B
Net Profit Margin
2.47%
TTM Avg
3.11%
3Y Avg
3.37%
5Y Avg
3.60%
Market Cap
$82.11B
Net Profit Margin
27.86%
TTM Avg
31.24%
3Y Avg
32.06%
5Y Avg
36.64%
Market Cap
$76.09B
Net Profit Margin
17.47%
TTM Avg
12.73%
3Y Avg
10.54%
5Y Avg
8.34%
Market Cap
$129.94B
Net Profit Margin
18.87%
TTM Avg
-1.95%
3Y Avg
6.91%
5Y Avg
3.60%
| NAME | MARKET CAP | NET PROFIT MARGIN | TTM | 3Y | 5Y |
|---|---|---|---|---|---|
| GSK plc (GSK) | $101.98B | 5.17% | 15.39% | 13.61% | 15.39% |
| McKesson Corporation (MCK)vs › | $105.58B | 1.12% | 1.05% | 1.09% | 0.48% |
| HCA Healthcare, Inc. (HCA)vs › | $89.08B | 8.77% | 8.57% | 8.64% | 8.95% |
| Medtronic plc (MDT)vs › | $116.07B | 13.20% | 13.55% | 12.62% | 13.06% |
| Elevance Health Inc. (ELV)vs › | $84.66B | 2.47% | 3.11% | 3.37% | 3.60% |
| CVS Health Corp. (CVS)vs › | $119.30B | 1.18% | 0.84% | 1.34% | 1.79% |
| Regeneron Pharmaceuticals, Inc. (REGN)vs › | $82.11B | 27.86% | 31.24% | 32.06% | 36.64% |
| Boston Scientific Corporation (BSX)vs › | $76.09B | 17.47% | 12.73% | 10.54% | 8.34% |
| Bristol-Myers Squibb Company (BMY)vs › | $129.94B | 18.87% | -1.95% | 6.91% | 3.60% |
| Cigna Corporation (CI)vs › | $72.37B | 2.27% | 1.78% | 2.48% | 3.04% |
Operating Margin
20.7%
Net Profit Margin
5.2%
Net Profit Margin = Net Income / Revenue
Net profit margin is the percentage of revenue that becomes net income after all expenses, taxes, and interest.
Expanded definitions: Investopedia, Wikipedia, Corporate Finance Institute
| DATE | NET PROFIT MARGIN |
|---|---|
| 2026-06-30 | 5.17% |
| 2026-03-31 | 22.77% |
| 2025-12-31 | 7.38% |
| 2025-09-30 | 23.55% |
| 2025-06-30 | 18.07% |
| 2025-03-31 | 21.61% |
| 2024-12-31 | 5.10% |
| 2024-09-30 | -0.72% |
| 2024-06-30 | 14.88% |
| 2024-03-31 | 14.21% |
| 2023-12-31 | 4.35% |
| 2023-09-30 | 17.97% |
| 2023-06-30 | 22.62% |
| 2023-03-31 | 21.44% |
| 2022-12-31 | 19.81% |
| 2022-09-30 | 138.22% |
| 2022-06-30 | 12.09% |
| 2022-03-31 | 25.06% |
| 2021-12-31 | 7.86% |
| 2021-09-30 | 20.64% |
| 2021-06-30 | 23.90% |
| 2021-03-31 | 14.46% |
| 2020-12-31 | 7.75% |
| 2020-09-30 | 14.39% |
| 2020-06-30 | 29.68% |
| 2020-03-31 | 17.22% |
| 2019-12-31 | 14.60% |
| 2019-09-30 | 16.54% |
| 2019-06-30 | 12.34% |
| 2019-03-31 | 10.83% |
| 2018-12-31 | 14.82% |
| 2018-09-30 | 17.52% |
| 2018-06-30 | 6.03% |
| 2018-03-31 | 7.60% |
| 2017-12-31 | -7.15% |
| 2017-09-30 | 15.45% |
| 2017-06-30 | -2.46% |
| 2017-03-31 | 14.17% |
| 2016-12-31 | 3.39% |
| 2016-09-30 | 10.71% |
| 2016-06-30 | -6.66% |
| 2016-03-31 | 4.53% |
| 2015-12-31 | -5.63% |
| 2015-09-30 | 8.78% |
| 2015-06-30 | 2.53% |
| 2015-03-31 | 143.88% |
| 2014-12-31 | 16.70% |
| 2014-09-30 | 7.10% |
| 2014-06-30 | 11.76% |
| 2014-03-31 | 11.90% |
| 2013-12-31 | 35.64% |
| 2013-09-30 | 14.88% |
| 2013-06-30 | 15.79% |
| 2013-03-31 | 14.85% |
| 2012-12-31 | 12.70% |
| 2012-09-30 | 16.93% |
| 2012-06-30 | 19.16% |
| 2012-03-31 | 19.70% |
| 2011-12-31 | 17.94% |
| 2011-09-30 | 19.40% |
| 2011-06-30 | 16.46% |
| 2011-03-31 | 23.16% |
| 2010-12-31 | -9.59% |
| 2010-09-30 | 18.91% |
| 2010-06-30 | -4.33% |
| 2010-03-31 | 18.21% |
| 2009-12-31 | 20.14% |
| 2009-09-30 | 19.75% |
| 2009-06-30 | 21.27% |
| 2009-03-31 | 16.71% |
| 2008-12-31 | 14.72% |
| 2008-09-30 | 17.46% |
| 2008-06-30 | 21.89% |
| 2008-03-31 | 22.99% |
| 2007-12-31 | 17.71% |
| 2007-09-30 | 23.93% |
| 2007-06-30 | 23.49% |
| 2007-03-31 | 27.07% |
| 2006-12-31 | 19.82% |
| 2006-09-30 | 24.65% |
| 2006-06-30 | 22.63% |
| 2006-03-31 | 25.84% |
| 2005-12-31 | 18.99% |
| 2005-09-30 | 22.06% |
| 2005-06-30 | 22.67% |
| 2005-03-31 | 23.87% |
| 2004-12-31 | 21.63% |
| 2004-09-30 | 20.47% |
| 2004-06-30 | 21.91% |
| 2004-03-31 | 21.36% |
| 2003-12-31 | 14.62% |
| 2003-09-30 | 21.30% |
| 2003-06-30 | 24.84% |
| 2003-03-31 | 22.94% |
| 2002-12-31 | 16.58% |
| 2002-09-30 | 15.74% |
